Catalog No.
EVV45101
Expression system
Mammalian cells
Species
Yellow fever virus (YFV)
Protein length
Ala1-Ser395
Predicted molecular weight
43.98 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q89293
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Envelope protein, E
Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein., PMID:40378003
A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses., PMID:40364846
Mechanism of Inhibition of the Active Triphosphate Form of 2'-α-Fluoro,2'-β-bromouridine against Yellow Fever Virus RNA-Dependent RNA Polymerase., PMID:40323779
Yellow fever virus infection alters mitochondrial network dynamics and trigger IFN-I response via TLR2 pathway., PMID:40300356
Bothropstoxins I and II as potent phospholipase A2 molecules from Bothrops jararacussu to impair hepatitis C virus infection., PMID:40288437
Immunoenzyme Test for Capture of IgM Anti-YFV Class Antibodies: MAC-ELISA., PMID:40249441
Micro-Focus Reduction Neutralization Tests (mFRNT) for Neutralizing Antibody (Nab) Quantification Against Yellow Fever Virus., PMID:40249436
Purification of Yellow Fever Virus by Liquid Chromatography., PMID:40249428
Type I Interferon-Induced Modification of Yellow Fever Virus NS5 Enhances Binding to Human STAT2., PMID:40249426
Immunofluorescence Assay., PMID:40249425
Immunoenzyme Test for Detection of IgG Anti-YFV Class Antibodies: IgG-ELISA., PMID:40249424
Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa., PMID:40207881
Histopathological Changes and Immune Response Profile in the Brains of Non-Human Primates Naturally Infected with Yellow Fever Virus., PMID:40143314
Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort., PMID:40019865
A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity., PMID:40019254
Antiviral metabolites from Passiflora edulis: An in vitro, phytochemical, and computational studies., PMID:39945526
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy., PMID:39886145
Dengue virus is particularly sensitive to interference with long-chain fatty acid elongation and desaturation., PMID:39863099
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future., PMID:39840044
Dengue and Zika virus NS4B proteins differ in topology and in determinants of ER membrane protein complex dependency., PMID:39745435
Undetected circulation of major arboviruses in West Sudan: urging for institutionalizing multisectoral one health strategy for the preparedness, prevention, and control of zoonotic arboviral diseases., PMID:39726037
Detection of neutralizing antibodies against arboviruses from liver homogenates., PMID:39671423
Wild Brazilian yellow fever virus infection in Syrian hamsters (Mesocricetus auratus): Clinical and histopathological analyses., PMID:39622385
Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1., PMID:39454515
2'-O-methyltransferase-deficient yellow fever virus: Restricted replication in the midgut and secondary tissues of Aedes aegypti mosquitoes severely limits dissemination., PMID:39356716
High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development., PMID:39291820
Insect cell production of chimeric virus-like particles based on human immunodeficiency virus GAG proteins and yellow fever virus envelope protein., PMID:39254800
Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights., PMID:39205212
Structural Insights into the Dynamic Assembly of a YFV sNS1 Tetramer., PMID:39205186
The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics., PMID:39203991
No Yellow Fever Vaccine Reactions in IgE-Mediated Egg Allergic Patients., PMID:39137738
Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels., PMID:39066237
Serological Evidence of Zika Virus Infections in Sudan., PMID:39066208
Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model., PMID:39019010
Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model., PMID:38932129
Baculovirus surface display of a chimeric E-NS1 protein of YFV protects against YFV infection., PMID:38852036
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses., PMID:38819991
Comparison of Five Serological Methods for the Detection of West Nile Virus Antibodies., PMID:38793670
[Preparation of monoclonal antibodies against the envelope protein extracellular domain of Zika virus in mice]., PMID:38790101
Advancing molecular modeling and reverse vaccinology in broad-spectrum yellow fever virus vaccine development., PMID:38735993
Residue K28 of Zika Virus NS5 Protein Is Implicated in Virus Replication and Antagonism of STAT2., PMID:38674605
Differentiation marker-negative CD4+ T cells persist after yellow fever virus vaccination and contribute to durable memory., PMID:38559113
Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil., PMID:38511952
The Role of Noncoding RNA in the Transmission and Pathogenicity of Flaviviruses., PMID:38400018
Development of a quantitative NS1 antigen enzyme-linked immunosorbent assay (ELISA) for Zika virus detection using a novel virus-specific mAb., PMID:38291109
Yellow fever virus infection in human hepatocyte cells triggers an imbalance in redox homeostasis with increased reactive oxygen species production, oxidative stress, and decreased antioxidant enzymes., PMID:38278309
Generation of Viral Particles with Brain Cell-Specific Tropism by Pseudotyping HIV-1 with the Zika Virus E Protein., PMID:38251196
Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions., PMID:38163752
Elongation of N6-benzyladenosine scaffold via Pd-catalyzed C-C bond formation leads to derivatives with antiflaviviral activity., PMID:38128296
Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for Arboviruses with clinical and immunological insights., PMID:38123499
For research use only. Not for human or drug use.
